Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment

Overview of attention for article published in International Journal of Bipolar Disorders, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 71 Mendeley

Summary Policy documents Wikipedia Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 20 Feb 2020

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.